318 related articles for article (PubMed ID: 32408641)
1. Hypersensitivity Reactions to Monoclonal Antibodies in Children.
Mori F; Saretta F; Bianchi A; Crisafulli G; Caimmi S; Liotti L; Bottau P; Franceschini F; Paglialunga C; Ricci G; Santoro A; Caffarelli C
Medicina (Kaunas); 2020 May; 56(5):. PubMed ID: 32408641
[TBL] [Abstract][Full Text] [Related]
2. Current Knowledge and Management of Hypersensitivity Reactions to Monoclonal Antibodies.
Picard M; Galvão VR
J Allergy Clin Immunol Pract; 2017; 5(3):600-609. PubMed ID: 28110056
[TBL] [Abstract][Full Text] [Related]
3. Hypersensitivity reactions to therapeutic monoclonal antibodies: Phenotypes and endotypes.
Isabwe GAC; Garcia Neuer M; de Las Vecillas Sanchez L; Lynch DM; Marquis K; Castells M
J Allergy Clin Immunol; 2018 Jul; 142(1):159-170.e2. PubMed ID: 29518427
[TBL] [Abstract][Full Text] [Related]
4. Hypersensitivity reactions to biologics in children.
de Las Vecillas L; Caimmi D; Isabwe GAC; Madrigal-Burgaleta R; Soyer O; Tanno L; Vultaggio A; Giovannini M; Mori F
Expert Opin Biol Ther; 2023 Jan; 23(1):61-72. PubMed ID: 36314361
[TBL] [Abstract][Full Text] [Related]
5. Hypersensitivity reactions to mAbs: 105 desensitizations in 23 patients, from evaluation to treatment.
Brennan PJ; Rodriguez Bouza T; Hsu FI; Sloane DE; Castells MC
J Allergy Clin Immunol; 2009 Dec; 124(6):1259-66. PubMed ID: 19910036
[TBL] [Abstract][Full Text] [Related]
6. Road Less Traveled: Drug Hypersensitivity to Fluoroquinolones, Vancomycin, Tetracyclines, and Macrolides.
Zhu LJ; Liu AY; Wong PH; Arroyo AC
Clin Rev Allergy Immunol; 2022 Jun; 62(3):505-518. PubMed ID: 35092578
[TBL] [Abstract][Full Text] [Related]
7. Adverse Reactions to Biologic Therapy.
Patel SV; Khan DA
Immunol Allergy Clin North Am; 2017 May; 37(2):397-412. PubMed ID: 28366484
[TBL] [Abstract][Full Text] [Related]
8. Management of Children with Hypersensitivity to Antibiotics and Monoclonal Antibodies.
Norton AE; Broyles AD
Immunol Allergy Clin North Am; 2017 Nov; 37(4):713-725. PubMed ID: 28965636
[TBL] [Abstract][Full Text] [Related]
9. Management of adverse reactions to biologic agents.
Isabwe GAC; de Las Vecillas Sanchez L; Castells M
Allergy Asthma Proc; 2017 Nov; 38(6):409-418. PubMed ID: 29046192
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and management of drug hypersensitivity reactions.
Romano A; Torres MJ; Castells M; Sanz ML; Blanca M
J Allergy Clin Immunol; 2011 Mar; 127(3 Suppl):S67-73. PubMed ID: 21354502
[TBL] [Abstract][Full Text] [Related]
11. Hypersensitivity to Rituximab in Children.
Liccioli G; Simonini G; Melani F; Giovannini M; Ricci S; Sarti L; Cavallin M; Barni S; Marrani E; Mori F
Pharmacology; 2021; 106(5-6):341-344. PubMed ID: 33202411
[TBL] [Abstract][Full Text] [Related]
12. Hypersensitivity reactions to biological drugs.
Corominas M; Gastaminza G; Lobera T
J Investig Allergol Clin Immunol; 2014; 24(4):212-25; quiz 1p following 225. PubMed ID: 25219103
[TBL] [Abstract][Full Text] [Related]
13. Rapid drug desensitization for hypersensitivity reactions to chemotherapy and monoclonal antibodies in the 21st century.
Castells Guitart MC
J Investig Allergol Clin Immunol; 2014; 24(2):72-9; quiz 2 p following 79. PubMed ID: 24834769
[TBL] [Abstract][Full Text] [Related]
14. Severe hypersensitivity reactions to biological drugs in children with rheumatic diseases.
Soyer O; Demir S; Bilginer Y; Batu ED; Sonmez HE; Arıcı ZS; Şahiner ÜM; Sekerel BE; Ozen S
Pediatr Allergy Immunol; 2019 Dec; 30(8):833-840. PubMed ID: 31419311
[TBL] [Abstract][Full Text] [Related]
15. Re-visiting Hypersensitivity Reactions to Taxanes: A Comprehensive Review.
Picard M; Castells MC
Clin Rev Allergy Immunol; 2015 Oct; 49(2):177-91. PubMed ID: 24740483
[TBL] [Abstract][Full Text] [Related]
16. Hypersensitivity reactions and anaphylaxis to checkpoint inhibitor-monoclonal antibodies and desensitization.
Labella M; Castells M
Ann Allergy Asthma Immunol; 2021 Jun; 126(6):623-629. PubMed ID: 33781937
[TBL] [Abstract][Full Text] [Related]
17. Utilizing Biologics in Drug Desensitization.
Yang BC; Castells MC
Curr Allergy Asthma Rep; 2023 Jan; 23(1):1-11. PubMed ID: 36445652
[TBL] [Abstract][Full Text] [Related]
18. Rituximab Hypersensitivity: From Clinical Presentation to Management.
Fouda GE; Bavbek S
Front Pharmacol; 2020; 11():572863. PubMed ID: 33013416
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic evaluation and risk factors for drug allergies in children: from clinical history to skin and challenge tests.
Arikoglu T; Aslan G; Batmaz SB; Eskandari G; Helvaci I; Kuyucu S
Int J Clin Pharm; 2015 Aug; 37(4):583-91. PubMed ID: 25822038
[TBL] [Abstract][Full Text] [Related]
20. Desensitization for hypersensitivity reactions to medications.
del Carmen Sancho M; Breslow R; Sloane D; Castells M
Chem Immunol Allergy; 2012; 97():217-33. PubMed ID: 22613865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
